Autopsy report · NCT02396628
Ruxolitinib In GvHD
Cause of deathSlow enrollment
“impossibility to recruit in the BAT arm”
Life of this trial
- Registered 2 years 4 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 22 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Prof. Dr. Nikolas von Bubnoff
- Sponsor type
- University, hospital or other
- Conditions
- Graft vs Host Disease
- Interventions
- Experimental intervention; Standard treatment
- Participants
- 22
- Sites
- 11
- Countries
- Germany
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.